VERIGRAFT
2 known investors
Find your way into VERIGRAFT
Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally. The company's proprietary technology creates biological solutions for conditions such as chronic venous insufficiency, peripheral arterial disease, and heart valve disease.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does VERIGRAFT do?
- Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally. The company's proprietary technology creates biological solutions for conditions such as chronic venous insufficiency, peripheral arterial disease, and heart valve disease.
- Who are VERIGRAFT's investors?
- VERIGRAFT's investors include Capital Cell, Scientia Ventures.